ADAR1 Capital Management’s Lexeo Therapeutics LXEO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$583K	Sell	145,109 -25,339	-15%	-$102K	0.09%	104
2025 Q1	$591K	Buy	170,448 +943	+0.6%	+$3.27K	0.11%	92
2024 Q4	$1.12M	Buy	169,505 +112,339	+197%	+$739K	0.22%	69
2024 Q3	$517K	Buy	57,166 +55,866	+4,297%	+$505K	0.08%	103
2024 Q2	$20.9K	Buy	+1,300	New	+$20.9K	﹤0.01%	204